Vivo Capital VIII, LLC - 23 Apr 2025 SCHEDULE 13D/A Report for Sinovac Biotech Ltd. Common Shares, $0.001 par value per share (SVA)

Filing Manager
Vivo Capital VIII, LLC
Reporting Manager
Vivo Capital IX, LLC
Security
Sinovac Biotech Ltd. Common Shares, $0.001 par value per share
Symbol
SVA
Shares outstanding
72,054,857 shares
Disclosed Ownership
4,539,456 shares
Ownership
6.3%
Form type
SCHEDULE 13D/A
Filing time
24 Apr 2025, 17:00:03 UTC
Date of event
23 Apr 2025
Next filing
13 Jun 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Capital VIII, LLC 1.9% 1,360,544 0 1,360,544 /s/ Dr. Frank Kung Dr. Frank Kung, Managing Member 0001618789
Vivo Capital IX, LLC 6.3% 4,539,456 0 4,539,456 /s/ Dr. Frank Kung Dr. Frank Kung, Managing Member 0001750698